English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52810085    ???header.onlineuser??? :  782
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"govindan r"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-10 of 10  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2025-07-31 Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures Satpathy, S; Clark, NM; Chen, YJ; Hosseini, N; Chang, YH; Hsiao, Y; Lei, JT; Petralia, F; Chen, JS; Geffen, Y; Heiman, DI; Paul, I; Cho, H; Hollenberg, M; Marino, GB; Lin, KT; Mannan, R; White, CJ; Allen, J; Avanessian, SC; Kane, MH; Wolfe, A; Kinarivala, M; Liu, W; Anand, S; Lin, MW; Haines, M; Bergstrom, EJ; Hussey, G; Li, GX; Mani, DC; Fang, H; Jaehnig, EJ; Keshishian, H; Miller, B; Su, KY; Hsiao, YJ; Hsu, HH; Hsieh, MS; Hsu, KH; Monovoukas, A; Gohsman, S; Thorup, JR; Deng, Y; Akiyama, Y; Deng, E; Sheng-Wen Chen, E; Krek, A; Espinoza, R; Ma, W; Charytonowicz, D; Sebra, R; Lin, JH; Chen, YS; Hsu, YC; Lin, ZS; Chen, KC; Yeh, CW; Wang, YT; Lazar, AJ; Mesri, M; An, E; Zhang, X; Clauser, KR; Fenyö, D; Chinnaiyan, AM; Zhang, B; Ding, L; Ruggles, K; Newton, C; Zhang, H; Wang, P; Hostetter, G; Omenn, GS; Kumar-Sinha, C; Thiagarajan, M; Govindan, R; Paik, P; Parolia, A; Li, QK; Ma'ayan, A; Getz, GA; Dhanasekaran, SM; Robles, AI; Chang, GC; Yang, PC; Yu, SL; Chen, HY; Nesvizhskii, AI; Carr, SA; Mani, DR; Cieslik, MP; Chen, YJ; Gillette, MA
臺大學術典藏 2022-08-10T02:37:39Z Amivantamab in egfr exon 20 insertion- mutated non-small-cell lung cancer progressing on platinum chemotherapy: Initial results from the chrysalis phase i study Park K.; Haura E.B.; Leighl N.B.; Mitchell P.; Shu C.A.; Girard N.; Viteri S.; Han J.-Y.; Kim S.-W.; Lee C.K.; Sabari J.K.; Spira A.I.; Yang T.-Y.; Kim D.-W.; Lee K.H.; Sanborn R.E.; Trigo J.; Goto K.; Lee J.-S.; CHIH-HSIN YANG; Govindan R.; Bauml J.M.; Garrido P.; Krebs M.G.; Reckamp K.L.; Xie J.; Curtin J.C.; Haddish-Berhane N.; Roshak A.; Millington D.; Lorenzini P.; Thayu M.; Knoblauch R.E.; Cho B.C.
臺大學術典藏 2020-05-26T09:26:49Z Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: A phase II global study Spira A; Bordogna W; Balas B; Morcos P.N; Monnet A; Zeaiter A; Kim D.-W.; Kim D.-W.;Zeaiter A;Monnet A;Morcos P.N;Balas B;Bordogna W;Spira A;Mekhail T;Ramirez S.V;Bearz A;Moro-Sibilot D;Lena H;Hughes B;Chih-Hsin Yang;Govindan R;De Petris L;Ahn J.S;Ou S.-H.I; Ou S.-H.I; Ahn J.S; De Petris L; Govindan R; CHIH-HSIN YANG; Hughes B; Lena H; Moro-Sibilot D; Bearz A; Ramirez S.V; Mekhail T
臺大學術典藏 2020-05-26T09:26:49Z Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: A phase II global study Spira A; Bordogna W; Balas B; Morcos P.N; Monnet A; Zeaiter A; Kim D.-W.; Kim D.-W.;Zeaiter A;Monnet A;Morcos P.N;Balas B;Bordogna W;Spira A;Mekhail T;Ramirez S.V;Bearz A;Moro-Sibilot D;Lena H;Hughes B;Chih-Hsin Yang;Govindan R;De Petris L;Ahn J.S;Ou S.-H.I; Ou S.-H.I; Ahn J.S; De Petris L; Govindan R; CHIH-HSIN YANG; Hughes B; Lena H; Moro-Sibilot D; Bearz A; Ramirez S.V; Mekhail T
臺大學術典藏 2020-05-26T09:26:43Z Pooled analysis of CNS response to alectinib in two studies of pretreated patients with ALK-positive non-small-cell lung cancer Ou S.-H.I.;Zeaiter A;Golding S;Bordogna W;Han J.-Y;Chih-Hsin Yang;Tessmer A;Dansin E;De Pas T;Crino L;Duruisseaux M;Moro-Sibilot D.L;Chiappori A;Kim D.-W;De Petris L;Camidge D.R;Socinski M.A;Gandhi L;Govindan R;Shaw A.T;Gadgeel S.M; Gadgeel S.M; Shaw A.T; Govindan R; Gandhi L; Socinski M.A; Camidge D.R; De Petris L; Kim D.-W; Chiappori A; Moro-Sibilot D.L; Duruisseaux M; Crino L; De Pas T; Dansin E; Tessmer A; CHIH-HSIN YANG; Han J.-Y; Bordogna W; Golding S; Zeaiter A; Ou S.-H.I.
臺大學術典藏 2020-05-26T09:26:43Z Pooled analysis of CNS response to alectinib in two studies of pretreated patients with ALK-positive non-small-cell lung cancer Ou S.-H.I.;Zeaiter A;Golding S;Bordogna W;Han J.-Y;Chih-Hsin Yang;Tessmer A;Dansin E;De Pas T;Crino L;Duruisseaux M;Moro-Sibilot D.L;Chiappori A;Kim D.-W;De Petris L;Camidge D.R;Socinski M.A;Gandhi L;Govindan R;Shaw A.T;Gadgeel S.M; Gadgeel S.M; Shaw A.T; Govindan R; Gandhi L; Socinski M.A; Camidge D.R; De Petris L; Kim D.-W; Chiappori A; Moro-Sibilot D.L; Duruisseaux M; Crino L; De Pas T; Dansin E; Tessmer A; CHIH-HSIN YANG; Han J.-Y; Bordogna W; Golding S; Zeaiter A; Ou S.-H.I.
臺大學術典藏 2020-05-26T09:26:36Z Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer Shaw A.T.;Zeaiter A;Morcos P.N;Balas B;Bordogna W;Golding S;Dansin E;Ahn J.S;Popat S;Lena H;Crino L;Dingemans A.-M.C;Govindan R;Barlesi F;Kim D.-W;Gandhi L;Gadgeel S;De Petris L;Ou S.-H.I;Chih-Hsin Yang; CHIH-HSIN YANG; Ou S.-H.I; De Petris L; Gadgeel S; Gandhi L; Kim D.-W; Barlesi F; Govindan R; Dingemans A.-M.C; Crino L; Lena H; Popat S; Ahn J.S; Dansin E; Golding S; Bordogna W; Balas B; Morcos P.N; Zeaiter A; Shaw A.T.
臺大學術典藏 2020-05-26T09:26:36Z Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer Shaw A.T.;Zeaiter A;Morcos P.N;Balas B;Bordogna W;Golding S;Dansin E;Ahn J.S;Popat S;Lena H;Crino L;Dingemans A.-M.C;Govindan R;Barlesi F;Kim D.-W;Gandhi L;Gadgeel S;De Petris L;Ou S.-H.I;Chih-Hsin Yang; CHIH-HSIN YANG; Ou S.-H.I; De Petris L; Gadgeel S; Gandhi L; Kim D.-W; Barlesi F; Govindan R; Dingemans A.-M.C; Crino L; Lena H; Popat S; Ahn J.S; Dansin E; Golding S; Bordogna W; Balas B; Morcos P.N; Zeaiter A; Shaw A.T.
臺大學術典藏 2020-05-26T09:26:17Z Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer Ou S.-H.I;Gadgeel S.M;Barlesi F;Chih-Hsin Yang;De Petris L;Kim D.-W;Govindan R;Dingemans A.-M;Crino L;L?na H;Popat S;Ahn J.S;Dansin E;Mitry E;M?ller B;Bordogna W;Balas B;Morcos P.N;Shaw A.T.; Ou S.-H.I; Gadgeel S.M; Barlesi F; CHIH-HSIN YANG; De Petris L; Kim D.-W; Govindan R; Dingemans A.-M; Crino L; Léna H; Popat S; Ahn J.S; Dansin E; Mitry E; Müller B; Bordogna W; Balas B; Morcos P.N; Shaw A.T.
臺大學術典藏 2020-05-26T09:26:17Z Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer Ou S.-H.I;Gadgeel S.M;Barlesi F;Chih-Hsin Yang;De Petris L;Kim D.-W;Govindan R;Dingemans A.-M;Crino L;L?na H;Popat S;Ahn J.S;Dansin E;Mitry E;M?ller B;Bordogna W;Balas B;Morcos P.N;Shaw A.T.; Ou S.-H.I; Gadgeel S.M; Barlesi F; CHIH-HSIN YANG; De Petris L; Kim D.-W; Govindan R; Dingemans A.-M; Crino L; Léna H; Popat S; Ahn J.S; Dansin E; Mitry E; Müller B; Bordogna W; Balas B; Morcos P.N; Shaw A.T.

Showing items 1-10 of 10  (1 Page(s) Totally)
1 
View [10|25|50] records per page